Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 2
2017 8
2018 9
2019 8
2020 8
2021 5
2022 6
2023 9
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions.
Marshall AD, Willing AR, Kairouz A, Cunningham EB, Wheeler A, O'Brien N, Perera V, Ward JW, Hiebert L, Degenhardt L, Hajarizadeh B, Colledge S, Hickman M, Jawad D, Lazarus JV, Matthews GV, Scheibe A, Vickerman P, Dore GJ, Grebely J; Global HCV and HIV Treatment Restrictions Group. Marshall AD, et al. Among authors: cunningham eb. Lancet Gastroenterol Hepatol. 2024 Apr;9(4):366-382. doi: 10.1016/S2468-1253(23)00335-7. Epub 2024 Feb 15. Lancet Gastroenterol Hepatol. 2024. PMID: 38367631 Review.
Scale-up of Direct-Acting Antiviral Treatment in Prisons Is Both Cost-effective and Key to Hepatitis C Virus Elimination.
Shih STF, Stone J, Martin NK, Hajarizadeh B, Cunningham EB, Kwon JA, McGrath C, Grant L, Grebely J, Dore GJ, Lloyd AR, Vickerman P, Chambers GM. Shih STF, et al. Among authors: cunningham eb. Open Forum Infect Dis. 2023 Dec 18;11(2):ofad637. doi: 10.1093/ofid/ofad637. eCollection 2024 Feb. Open Forum Infect Dis. 2023. PMID: 38344130 Free PMC article.
Health-Related Quality of Life of People Who Inject Drugs: The Enhancing Treatment of Hepatitis C in Opioid Substitution Settings Engage Study.
Cheng Q, Valerio H, Cunningham EB, Shih STF, Silk D, Conway A, Treloar C, Murray C, Henderson C, Amin J, Read P, Dore GJ, Grebely J; ETHOS Engage Study Group. Cheng Q, et al. Among authors: cunningham eb. Value Health. 2024 Feb;27(2):216-225. doi: 10.1016/j.jval.2023.10.013. Epub 2023 Nov 10. Value Health. 2024. PMID: 37951538 Free article.
Optimizing point-of-care testing strategies for diagnosis and treatment of hepatitis C virus infection in Australia: a model-based cost-effectiveness analysis.
Shih STF, Cheng Q, Carson J, Valerio H, Sheehan Y, Gray RT, Cunningham EB, Kwon JA, Lloyd AR, Dore GJ, Wiseman V, Grebely J. Shih STF, et al. Among authors: cunningham eb. Lancet Reg Health West Pac. 2023 Apr 4;36:100750. doi: 10.1016/j.lanwpc.2023.100750. eCollection 2023 Jul. Lancet Reg Health West Pac. 2023. PMID: 37547040 Free PMC article.
Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic review.
Colledge-Frisby S, Ottaviano S, Webb P, Grebely J, Wheeler A, Cunningham EB, Hajarizadeh B, Leung J, Peacock A, Vickerman P, Farrell M, Dore GJ, Hickman M, Degenhardt L. Colledge-Frisby S, et al. Among authors: cunningham eb. Lancet Glob Health. 2023 May;11(5):e673-e683. doi: 10.1016/S2214-109X(23)00058-X. Epub 2023 Mar 27. Lancet Glob Health. 2023. PMID: 36996860 Free article.
Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review.
Degenhardt L, Webb P, Colledge-Frisby S, Ireland J, Wheeler A, Ottaviano S, Willing A, Kairouz A, Cunningham EB, Hajarizadeh B, Leung J, Tran LT, Price O, Peacock A, Vickerman P, Farrell M, Dore GJ, Hickman M, Grebely J. Degenhardt L, et al. Among authors: cunningham eb. Lancet Glob Health. 2023 May;11(5):e659-e672. doi: 10.1016/S2214-109X(23)00057-8. Epub 2023 Mar 27. Lancet Glob Health. 2023. PMID: 36996857 Free article.
A national programme to scale-up decentralised hepatitis C point-of-care testing and treatment in Australia.
Grebely J, Markus C, Causer LM, Silk D, Comben S, Lloyd AR, Martinez M, Cunningham EB, O'Flynn M, Dore GJ, Matthews S; National Australian Hepatitis C Point-of-Care Testing Program. Grebely J, et al. Among authors: cunningham eb. Lancet Gastroenterol Hepatol. 2023 Mar;8(3):204-207. doi: 10.1016/S2468-1253(22)00355-7. Lancet Gastroenterol Hepatol. 2023. PMID: 36773609 No abstract available.
51 results